AMICUS THERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Amicus Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Amicus Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -15.9 %, a 37.6% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Return On Assets for 2023 was -20.4 %, a 32.9% increase from 2022.
  • Amicus Therapeutics, Inc. annual Return On Assets for 2022 was -30.4 %, a 5.01% decline from 2021.
  • Amicus Therapeutics, Inc. annual Return On Assets for 2021 was -29 %, a 15.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -15.9 +9.57 +37.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -19.7 +7.72 +28.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -20.4 +10 +32.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.8 +8.28 +25.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -25.4 +6.78 +21% Apr 1, 2023 Jun 30, 2023
Q1 2023 -27.4 +3.71 +11.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.4 -1.45 -5.01% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.1 -4.33 -15.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.2 -2.39 -8.01% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.1 -0.33 -1.07% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29 +5.35 +15.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -27.7 +9.27 +25% Jul 1, 2021 Sep 30, 2021
Q2 2021 -29.8 +7.12 +19.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.8 +7.62 +19.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -34.3 +7.42 +17.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -37 +4.1 +9.98% Jul 1, 2020 Sep 30, 2020
Q2 2020 -36.9 +16.5 +30.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -38.4 +13.8 +26.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -41.7 +0.25 +0.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -41.1 +1.93 +4.49% Jul 1, 2019 Sep 30, 2019
Q2 2019 -53.4 -14.4 -37.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -52.1 -16.3 -45.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -42 -6.93 -19.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -43 -13.1 -43.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -39 -17.5 -81.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -35.8 -13.9 -63.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -35.1 -13.6 -63.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -30 -9.51 -46.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -21.5 -2.34 -12.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -21.9 -2.72 -14.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -21.4 -0.23 -1.08% Oct 1, 2016 Dec 31, 2016
Q3 2016 -20.5 +4.18 +17% Jul 1, 2016 Sep 30, 2016
Q2 2016 -19.1 +19.4 +50.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -19.2 +28.7 +59.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -21.2 +27.5 +56.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -24.6 +25 +50.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -38.5 +15.2 +28.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -47.8 +11.6 +19.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -48.7 +15.4 +24% Oct 1, 2014 Dec 31, 2014
Q3 2014 -49.6 +15.1 +23.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -53.8 +4.8 +8.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -59.4 -10.4 -21.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -64.1 -21.7 -51.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -64.7 -19.6 -43.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -58.6 -15.6 -36.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -49.1 +0.1 +0.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -42.4 Oct 1, 2012 Dec 31, 2012
Q3 2012 -45.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -42.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -49.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.